Today, the first up-close look at one of our 2010 DiabetesMine Design Challenge winners. Mauro Amoruso was honored with one of three Grand Prizes for his concept called Zero. It’s a combination insulin pump and continuous glucose monitor in a futuristic bracelet format:
Mauro is a 26-year-old freelance professional designer living in Turin, Italy. I spoke to him on the phone yesterday from across the world, with him repeatedly apologizing for his English. No worries…
Read more »
You heard of Medingo, right? The Israeli start-up company whose new patch pump technology was recently acquired by Accu-Chek/Roche Diabetes?
Well, there’s another Israeli start-up that’s presumably hoping to beat a similar path. The company is called NiliMedix, based in the country’s Haifa District. They’re developing both “advanced insulin pump technology” — a supposedly smaller, lighter and more sophisticated pump than any on the market today — and also “innovative measures for the most accurate…
Read more »
Novo Nordisk is well-known in the diabetes community for its insulins, Novolog and Levemir, used to treat mainly type 1 diabetes. But in the last year, Novo launched a new kind of injectable, a “first line of defense for people with type 2 diabetes” called Victoza (generic: liraglutide). It’s a glucagon-like peptide-1 (GLP-1) drug designed to stimulate insulin secretion when hyperglycemia (high blood sugar) is present.
Victoza is still the new kid on the block…
Read more »
By
AmyT on
March 12, 2010
Just when I thought I’d experienced every indignity and inconvenience this disease could dish up, along comes basal testing.
I’ve had the Big D for almost seven years now, and I’ve always been told never to skip meals (a good thing too, because I need my meals!). At the same time, I know you’re supposed to test your basal rates periodically to make sure your background insulin is doing what it’s supposed to. Admittedly, I…
Read more »
By
AmyT on
January 25, 2010
You’ve heard it before: someone with type 2 diabetes goes on insulin. That’s no surprise. But how often have you heard the reverse — someone with type 1 going on Metformin?
Since the launch of Symlin in 2005, it’s not uncommon for people to treat their type 1 diabetes with a supplemental injectable medication. But hang around long enough, and you too might get to know someone with type 1 who takes insulin and oral meds,…
Read more »
